首页>
外国专利>
MKK4 INHIBITOR AND THE PHARMACEUTICALLY ACCEPTABLE OPTICAL SALES, SOLVATES AND ISOMERS OF THE SAME, COMPOUND AND THE PHARMACEUTICALLY ACCEPTABLE PHARMACEUTICALLY ACCEPTABLE INITIATIVE KNOWLEDGE PROTECTION IN THE PROTEIN OF THE KNOWLEDGE
MKK4 INHIBITOR AND THE PHARMACEUTICALLY ACCEPTABLE OPTICAL SALES, SOLVATES AND ISOMERS OF THE SAME, COMPOUND AND THE PHARMACEUTICALLY ACCEPTABLE PHARMACEUTICALLY ACCEPTABLE INITIATIVE KNOWLEDGE PROTECTION IN THE PROTEIN OF THE KNOWLEDGE
the invention relates to mkk4 (mitogen-activated protein kinase 4) and its use in promoting liver regeneration or in reducing or preventing hepatocyte death. mkk4 inhibitors selectively inhibit protein kinase mkk4 over protein kinases jnk and mkk7.
展开▼
